Abbott announced recently that the U.S. Food and Drug Administration (FDA) has approved AndroGel (testosterone gel) 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starti

A dizzying number of factors can conspire against sexual desire as midlife approaches: depression, medications, illness, career worries, financial pressures, marriage troubles, young children in the home (or an empty nest), the sense that life is half ove

On May 29, 2011 XTL has announced that its rHuEPO drug which is currently in preparations for phase 2 clinical trial, has been granted an Orphan-drug designation by the US Food and Drug Administration (FDA) for treatment of Multiple Myeloma blood cancer.